Cyclacel Pharmaceuticals, Inc. (CYCC) Posts Q1 GAAP Loss of $1.18/Share

May 13, 2013 4:02 PM

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) reported ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found